Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher's AI Network Medicine ...
BRUNO GUIMARAES has informed Newcastle of his desire to join Arsenal this summer, according to reports. Meanwhile, former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results